APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Consumer Healthcare

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Consumer Healthcare Market Outlook and Growth Opportunities 2026

Report ID 173980670426 December 2025198 pages

Choose your research edition.

Industry ResearchConsumer Healthcare Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Consumer Healthcare Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Consumer Healthcare Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Consumer Healthcare Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Consumer Healthcare Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Consumer Healthcare market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Consumer Healthcare is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Consumer Healthcare is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Consumer Healthcare is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Consumer Healthcare market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Consumer Healthcare market include Abbott Laboratories, Glenmark Pharmaceuticals Ltd., Ipsen, Sanofi S.A., Piramal Enterprises Ltd., Sun Pharmaceuticals Ltd., Bayer AG, GlaxosmithKline plc, GSK and Pfizer, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Consumer Healthcare market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Consumer Healthcare and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Consumer Healthcare sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Consumer Healthcare market size, projected growth trends, production technologies, key applications, and end-use industries.

Consumer Healthcare Segment by Company

Abbott Laboratories

Glenmark Pharmaceuticals Ltd.

Ipsen, Sanofi S.A.

Piramal Enterprises Ltd.

Sun Pharmaceuticals Ltd.

Bayer AG

GlaxosmithKline plc

GSK

Pfizer, Inc.

Mylan

Merck

Johnson & Johnson

Sanofi

Consumer Healthcare Segment by Type

Respiratory Product

Oral Health Product

Skin Health Product

Nutrition/Gastro Intestinal Product

Pain Relief Product

Consumer Healthcare Segment by Application

Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

Consumer Healthcare Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Consumer Healthcare status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Consumer Healthcare market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Consumer Healthcare significant trends, drivers, influence factors in global and regions.

6. To analyze Consumer Healthcare competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Consumer Healthcare market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Consumer Healthcare and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Consumer Healthcare.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Consumer Healthcare market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Consumer Healthcare industry.

Chapter 3: Detailed analysis of Consumer Healthcare manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Consumer Healthcare in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Consumer Healthcare in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Consumer Healthcare Industry Trends Table 2. Consumer Healthcare Industry Drivers Table 3. Consumer Healthcare Industry Opportunities and Challenges Table 4. Consumer Healthcare Industry Restraints Table 5. Global Consumer Healthcare Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Consumer Healthcare Revenue Share by Company (2021-2026) Table 7. Global Consumer Healthcare Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Consumer Healthcare Sales Volume Share by Company (2021-2026) Table 9. Global Consumer Healthcare Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Consumer Healthcare Company Ranking, (2024-2026) & (USD Million) Table 11. Global Consumer Healthcare Key Company Manufacturing Base & Headquarters Table 12. Global Consumer Healthcare Company, Product Type & Application Table 13. Global Consumer Healthcare Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Consumer Healthcare by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Respiratory Product Table 18. Significant Companies of Oral Health Product Table 19. Significant Companies of Skin Health Product Table 20. Significant Companies of Nutrition/Gastro Intestinal Product Table 21. Significant Companies of Pain Relief Product Table 22. Global Consumer Healthcare Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Consumer Healthcare Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Consumer Healthcare Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Consumer Healthcare Sales Volume Share by Type (2021-2026) Table 26. Global Consumer Healthcare Sales Volume Share by Type (2027-2032) Table 27. Global Consumer Healthcare Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Consumer Healthcare Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Consumer Healthcare Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Consumer Healthcare Sales Value Share by Type (2021-2026) Table 31. Global Consumer Healthcare Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hospital Pharmacy Table 33. Significant Companies of Online Pharmacy Table 34. Significant Companies of Retail Pharmacy Table 35. Global Consumer Healthcare Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Consumer Healthcare Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Consumer Healthcare Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Consumer Healthcare Sales Volume Share by Application (2021-2026) Table 39. Global Consumer Healthcare Sales Volume Share by Application (2027-2032) Table 40. Global Consumer Healthcare Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Consumer Healthcare Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Consumer Healthcare Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Consumer Healthcare Sales Value Share by Application (2021-2026) Table 44. Global Consumer Healthcare Sales Value Share by Application (2027-2032) Table 45. Global Consumer Healthcare Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Consumer Healthcare Sales by Region (2021-2026) & (K Units) Table 47. Global Consumer Healthcare Sales Market Share by Region (2021-2026) Table 48. Global Consumer Healthcare Sales by Region (2027-2032) & (K Units) Table 49. Global Consumer Healthcare Sales Market Share by Region (2027-2032) Table 50. Global Consumer Healthcare Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Consumer Healthcare Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Consumer Healthcare Sales Value Share by Region (2021-2026) Table 53. Global Consumer Healthcare Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Consumer Healthcare Sales Value Share by Region (2027-2032) Table 55. Global Consumer Healthcare Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Consumer Healthcare Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Consumer Healthcare Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Consumer Healthcare Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Consumer Healthcare Sales by Country (2021-2026) & (K Units) Table 60. Global Consumer Healthcare Sales Market Share by Country (2021-2026) Table 61. Global Consumer Healthcare Sales by Country (2027-2032) & (K Units) Table 62. Global Consumer Healthcare Sales Market Share by Country (2027-2032) Table 63. Global Consumer Healthcare Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Consumer Healthcare Sales Value Market Share by Country (2021-2026) Table 65. Global Consumer Healthcare Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Consumer Healthcare Sales Value Market Share by Country (2027-2032) Table 67. Abbott Laboratories Company Information Table 68. Abbott Laboratories Business Overview Table 69. Abbott Laboratories Consumer Healthcare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Abbott Laboratories Consumer Healthcare Product Portfolio Table 71. Abbott Laboratories Recent Development Table 72. Glenmark Pharmaceuticals Ltd. Company Information Table 73. Glenmark Pharmaceuticals Ltd. Business Overview Table 74. Glenmark Pharmaceuticals Ltd. Consumer Healthcare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Glenmark Pharmaceuticals Ltd. Consumer Healthcare Product Portfolio Table 76. Glenmark Pharmaceuticals Ltd. Recent Development Table 77. Ipsen, Sanofi S.A. Company Information Table 78. Ipsen, Sanofi S.A. Business Overview Table 79. Ipsen, Sanofi S.A. Consumer Healthcare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Ipsen, Sanofi S.A. Consumer Healthcare Product Portfolio Table 81. Ipsen, Sanofi S.A. Recent Development Table 82. Piramal Enterprises Ltd. Company Information Table 83. Piramal Enterprises Ltd. Business Overview Table 84. Piramal Enterprises Ltd. Consumer Healthcare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Piramal Enterprises Ltd. Consumer Healthcare Product Portfolio Table 86. Piramal Enterprises Ltd. Recent Development Table 87. Sun Pharmaceuticals Ltd. Company Information Table 88. Sun Pharmaceuticals Ltd. Business Overview Table 89. Sun Pharmaceuticals Ltd. Consumer Healthcare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Sun Pharmaceuticals Ltd. Consumer Healthcare Product Portfolio Table 91. Sun Pharmaceuticals Ltd. Recent Development Table 92. Bayer AG Company Information Table 93. Bayer AG Business Overview Table 94. Bayer AG Consumer Healthcare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Bayer AG Consumer Healthcare Product Portfolio Table 96. Bayer AG Recent Development Table 97. GlaxosmithKline plc Company Information Table 98. GlaxosmithKline plc Business Overview Table 99. GlaxosmithKline plc Consumer Healthcare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. GlaxosmithKline plc Consumer Healthcare Product Portfolio Table 101. GlaxosmithKline plc Recent Development Table 102. GSK Company Information Table 103. GSK Business Overview Table 104. GSK Consumer Healthcare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. GSK Consumer Healthcare Product Portfolio Table 106. GSK Recent Development Table 107. Pfizer, Inc. Company Information Table 108. Pfizer, Inc. Business Overview Table 109. Pfizer, Inc. Consumer Healthcare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Pfizer, Inc. Consumer Healthcare Product Portfolio Table 111. Pfizer, Inc. Recent Development Table 112. Mylan Company Information Table 113. Mylan Business Overview Table 114. Mylan Consumer Healthcare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Mylan Consumer Healthcare Product Portfolio Table 116. Mylan Recent Development Table 117. Merck Company Information Table 118. Merck Business Overview Table 119. Merck Consumer Healthcare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Merck Consumer Healthcare Product Portfolio Table 121. Merck Recent Development Table 122. Johnson & Johnson Company Information Table 123. Johnson & Johnson Business Overview Table 124. Johnson & Johnson Consumer Healthcare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Johnson & Johnson Consumer Healthcare Product Portfolio Table 126. Johnson & Johnson Recent Development Table 127. Sanofi Company Information Table 128. Sanofi Business Overview Table 129. Sanofi Consumer Healthcare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Sanofi Consumer Healthcare Product Portfolio Table 131. Sanofi Recent Development Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Consumer Healthcare Distributors List Table 135. Consumer Healthcare Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Consumer Healthcare Product Image Figure 2. Global Consumer Healthcare Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Consumer Healthcare Sales Value (2021-2032) & (US$ Million) Figure 4. Global Consumer Healthcare Sales (2021-2032) & (K Units) Figure 5. Global Consumer Healthcare Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Consumer Healthcare Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Respiratory Product Image Figure 10. Oral Health Product Image Figure 11. Skin Health Product Image Figure 12. Nutrition/Gastro Intestinal Product Image Figure 13. Pain Relief Product Image Figure 14. Global Consumer Healthcare Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Consumer Healthcare Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Consumer Healthcare Sales Volume Share by Type (2021-2032) Figure 17. Global Consumer Healthcare Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Consumer Healthcare Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Consumer Healthcare Sales Value Share by Type (2021-2032) Figure 20. Hospital Pharmacy Image Figure 21. Online Pharmacy Image Figure 22. Retail Pharmacy Image Figure 23. Global Consumer Healthcare Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Consumer Healthcare Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Consumer Healthcare Sales Volume Share by Application (2021-2032) Figure 26. Global Consumer Healthcare Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Consumer Healthcare Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Consumer Healthcare Sales Value Share by Application (2021-2032) Figure 29. Global Consumer Healthcare Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Consumer Healthcare Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Consumer Healthcare Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Consumer Healthcare Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Consumer Healthcare Sales Value (2021-2032) & (US$ Million) Figure 34. North America Consumer Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Consumer Healthcare Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Consumer Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Consumer Healthcare Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Consumer Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Consumer Healthcare Sales Value (2021-2032) & (US$ Million) Figure 40. South America Consumer Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Consumer Healthcare Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Consumer Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Consumer Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Consumer Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Consumer Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Consumer Healthcare Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Consumer Healthcare Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Respiratory Product
  • Oral Health Product
  • Skin Health Product
  • Nutrition/Gastro Intestinal Product
  • Pain Relief Product
Applications
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
Companies covered
  • Abbott Laboratories
  • Glenmark Pharmaceuticals Ltd.
  • Ipsen, Sanofi S.A.
  • Piramal Enterprises Ltd.
  • Sun Pharmaceuticals Ltd.
  • Bayer AG
  • GlaxosmithKline plc
  • GSK
  • Pfizer, Inc.
  • Mylan
  • Merck
  • Johnson & Johnson
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Consumer Healthcare Sales Value (2021-2032)
  4. 1.2.2 Global Consumer Healthcare Sales Volume (2021-2032)
  5. 1.2.3 Global Consumer Healthcare Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Consumer Healthcare Market Dynamics
  1. 2.1 Consumer Healthcare Industry Trends
  2. 2.2 Consumer Healthcare Industry Drivers
  3. 2.3 Consumer Healthcare Industry Opportunities and Challenges
  4. 2.4 Consumer Healthcare Industry Restraints
3 Consumer Healthcare Market by Company
  1. 3.1 Global Consumer Healthcare Company Revenue Ranking in 2025
  2. 3.2 Global Consumer Healthcare Revenue by Company (2021-2026)
  3. 3.3 Global Consumer Healthcare Sales Volume by Company (2021-2026)
  4. 3.4 Global Consumer Healthcare Average Price by Company (2021-2026)
  5. 3.5 Global Consumer Healthcare Company Ranking (2024-2026)
  6. 3.6 Global Consumer Healthcare Company Manufacturing Base and Headquarters
  7. 3.7 Global Consumer Healthcare Company Product Type and Application
  8. 3.8 Global Consumer Healthcare Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Consumer Healthcare Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Consumer Healthcare Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Consumer Healthcare Market by Type
  1. 4.1 Consumer Healthcare Type Introduction
  2. 4.1.1 Respiratory Product
  3. 4.1.2 Oral Health Product
  4. 4.1.3 Skin Health Product
  5. 4.1.4 Nutrition/Gastro Intestinal Product
  6. 4.1.5 Pain Relief Product
  7. 4.2 Global Consumer Healthcare Sales Volume by Type
  8. 4.2.1 Global Consumer Healthcare Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Consumer Healthcare Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Consumer Healthcare Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Consumer Healthcare Sales Value by Type
  12. 4.3.1 Global Consumer Healthcare Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Consumer Healthcare Sales Value by Type (2021-2032)
  14. 4.3.3 Global Consumer Healthcare Sales Value Share by Type (2021-2032)
5 Consumer Healthcare Market by Application
  1. 5.1 Consumer Healthcare Application Introduction
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Retail Pharmacy
  5. 5.2 Global Consumer Healthcare Sales Volume by Application
  6. 5.2.1 Global Consumer Healthcare Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Consumer Healthcare Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Consumer Healthcare Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Consumer Healthcare Sales Value by Application
  10. 5.3.1 Global Consumer Healthcare Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Consumer Healthcare Sales Value by Application (2021-2032)
  12. 5.3.3 Global Consumer Healthcare Sales Value Share by Application (2021-2032)
6 Consumer Healthcare Regional Sales and Value Analysis
  1. 6.1 Global Consumer Healthcare Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Consumer Healthcare Sales by Region (2021-2032)
  3. 6.2.1 Global Consumer Healthcare Sales by Region: 2021-2026
  4. 6.2.2 Global Consumer Healthcare Sales by Region (2027-2032)
  5. 6.3 Global Consumer Healthcare Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Consumer Healthcare Sales Value by Region (2021-2032)
  7. 6.4.1 Global Consumer Healthcare Sales Value by Region: 2021-2026
  8. 6.4.2 Global Consumer Healthcare Sales Value by Region (2027-2032)
  9. 6.5 Global Consumer Healthcare Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Consumer Healthcare Sales Value (2021-2032)
  12. 6.6.2 North America Consumer Healthcare Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Consumer Healthcare Sales Value (2021-2032)
  15. 6.7.2 Europe Consumer Healthcare Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Consumer Healthcare Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Consumer Healthcare Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Consumer Healthcare Sales Value (2021-2032)
  21. 6.9.2 South America Consumer Healthcare Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Consumer Healthcare Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Consumer Healthcare Sales Value Share by Country, 2025 VS 2032
7 Consumer Healthcare Country-level Sales and Value Analysis
  1. 7.1 Global Consumer Healthcare Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Consumer Healthcare Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Consumer Healthcare Sales by Country (2021-2032)
  4. 7.3.1 Global Consumer Healthcare Sales by Country (2021-2026)
  5. 7.3.2 Global Consumer Healthcare Sales by Country (2027-2032)
  6. 7.4 Global Consumer Healthcare Sales Value by Country (2021-2032)
  7. 7.4.1 Global Consumer Healthcare Sales Value by Country (2021-2026)
  8. 7.4.2 Global Consumer Healthcare Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Consumer Healthcare Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Consumer Healthcare Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Consumer Healthcare Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Consumer Healthcare Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Consumer Healthcare Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Consumer Healthcare Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Consumer Healthcare Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Consumer Healthcare Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Consumer Healthcare Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Consumer Healthcare Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Consumer Healthcare Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Consumer Healthcare Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Consumer Healthcare Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Consumer Healthcare Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Consumer Healthcare Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Consumer Healthcare Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Consumer Healthcare Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Consumer Healthcare Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Consumer Healthcare Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Consumer Healthcare Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Consumer Healthcare Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Consumer Healthcare Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Consumer Healthcare Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Consumer Healthcare Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Consumer Healthcare Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Consumer Healthcare Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Consumer Healthcare Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Consumer Healthcare Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Consumer Healthcare Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Consumer Healthcare Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott Laboratories
  2. 8.1.1 Abbott Laboratories Company Information
  3. 8.1.2 Abbott Laboratories Business Overview
  4. 8.1.3 Abbott Laboratories Consumer Healthcare Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Laboratories Consumer Healthcare Product Portfolio
  6. 8.1.5 Abbott Laboratories Recent Developments
  7. 8.2 Glenmark Pharmaceuticals Ltd.
  8. 8.2.1 Glenmark Pharmaceuticals Ltd. Company Information
  9. 8.2.2 Glenmark Pharmaceuticals Ltd. Business Overview
  10. 8.2.3 Glenmark Pharmaceuticals Ltd. Consumer Healthcare Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Glenmark Pharmaceuticals Ltd. Consumer Healthcare Product Portfolio
  12. 8.2.5 Glenmark Pharmaceuticals Ltd. Recent Developments
  13. 8.3 Ipsen, Sanofi S.A.
  14. 8.3.1 Ipsen, Sanofi S.A. Company Information
  15. 8.3.2 Ipsen, Sanofi S.A. Business Overview
  16. 8.3.3 Ipsen, Sanofi S.A. Consumer Healthcare Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Ipsen, Sanofi S.A. Consumer Healthcare Product Portfolio
  18. 8.3.5 Ipsen, Sanofi S.A. Recent Developments
  19. 8.4 Piramal Enterprises Ltd.
  20. 8.4.1 Piramal Enterprises Ltd. Company Information
  21. 8.4.2 Piramal Enterprises Ltd. Business Overview
  22. 8.4.3 Piramal Enterprises Ltd. Consumer Healthcare Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Piramal Enterprises Ltd. Consumer Healthcare Product Portfolio
  24. 8.4.5 Piramal Enterprises Ltd. Recent Developments
  25. 8.5 Sun Pharmaceuticals Ltd.
  26. 8.5.1 Sun Pharmaceuticals Ltd. Company Information
  27. 8.5.2 Sun Pharmaceuticals Ltd. Business Overview
  28. 8.5.3 Sun Pharmaceuticals Ltd. Consumer Healthcare Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sun Pharmaceuticals Ltd. Consumer Healthcare Product Portfolio
  30. 8.5.5 Sun Pharmaceuticals Ltd. Recent Developments
  31. 8.6 Bayer AG
  32. 8.6.1 Bayer AG Company Information
  33. 8.6.2 Bayer AG Business Overview
  34. 8.6.3 Bayer AG Consumer Healthcare Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Bayer AG Consumer Healthcare Product Portfolio
  36. 8.6.5 Bayer AG Recent Developments
  37. 8.7 GlaxosmithKline plc
  38. 8.7.1 GlaxosmithKline plc Company Information
  39. 8.7.2 GlaxosmithKline plc Business Overview
  40. 8.7.3 GlaxosmithKline plc Consumer Healthcare Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 GlaxosmithKline plc Consumer Healthcare Product Portfolio
  42. 8.7.5 GlaxosmithKline plc Recent Developments
  43. 8.8 GSK
  44. 8.8.1 GSK Company Information
  45. 8.8.2 GSK Business Overview
  46. 8.8.3 GSK Consumer Healthcare Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 GSK Consumer Healthcare Product Portfolio
  48. 8.8.5 GSK Recent Developments
  49. 8.9 Pfizer, Inc.
  50. 8.9.1 Pfizer, Inc. Company Information
  51. 8.9.2 Pfizer, Inc. Business Overview
  52. 8.9.3 Pfizer, Inc. Consumer Healthcare Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer, Inc. Consumer Healthcare Product Portfolio
  54. 8.9.5 Pfizer, Inc. Recent Developments
  55. 8.10 Mylan
  56. 8.10.1 Mylan Company Information
  57. 8.10.2 Mylan Business Overview
  58. 8.10.3 Mylan Consumer Healthcare Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Mylan Consumer Healthcare Product Portfolio
  60. 8.10.5 Mylan Recent Developments
  61. 8.11 Merck
  62. 8.11.1 Merck Company Information
  63. 8.11.2 Merck Business Overview
  64. 8.11.3 Merck Consumer Healthcare Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Merck Consumer Healthcare Product Portfolio
  66. 8.11.5 Merck Recent Developments
  67. 8.12 Johnson & Johnson
  68. 8.12.1 Johnson & Johnson Company Information
  69. 8.12.2 Johnson & Johnson Business Overview
  70. 8.12.3 Johnson & Johnson Consumer Healthcare Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Johnson & Johnson Consumer Healthcare Product Portfolio
  72. 8.12.5 Johnson & Johnson Recent Developments
  73. 8.13 Sanofi
  74. 8.13.1 Sanofi Company Information
  75. 8.13.2 Sanofi Business Overview
  76. 8.13.3 Sanofi Consumer Healthcare Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Sanofi Consumer Healthcare Product Portfolio
  78. 8.13.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Consumer Healthcare Value Chain Analysis
  2. 9.1.1 Consumer Healthcare Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Consumer Healthcare Sales Mode & Process
  6. 9.2 Consumer Healthcare Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Consumer Healthcare Distributors
  9. 9.2.3 Consumer Healthcare Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst